most undervalued pharmaceutical Anyone watching this? i got in 70c (could have waited in retrospect - as always). Genepharm recently bought Douglas pharmaceutical for 70mil - a company with annual revenue of 55mil (no other figures given). LIP has half yrly revenue of 37mil. I KNOW - revenue means nothing coz profit is all that matters. i still think its undervalued with a market cap of 65mil at the moment. Any thoughts out there?
LIP
lipa pharmaceuticals limited
